Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
作者信息
Hao Fulong, Chen Xinyang, Li Hancong, Feng Qingbo, Hou Yong
机构信息
Department of Hepatobiliary Surgery Suining First People's Hospital, Suining, China.
West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
出版信息
J Gastrointest Oncol. 2023 Feb 28;14(1):478-479. doi: 10.21037/jgo-22-1090. Epub 2023 Jan 6.
Abstract
摘要
相似文献
1
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?以吉西他滨（GEM）为基础的联合疗法对晚期胰腺癌的治疗有效果吗？
J Gastrointest Oncol. 2023 Feb 28;14(1):478-479. doi: 10.21037/jgo-22-1090. Epub 2023 Jan 6.
2
Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.吉西他滨与S-1联合化疗对比单纯吉西他滨治疗局部晚期和转移性胰腺癌：一项亚洲随机对照试验的荟萃分析
J Chemother. 2015 Aug;27(4):227-34. doi: 10.1179/1973947815Y.0000000013. Epub 2015 Mar 20.
3
[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].[吉西他滨为主的化疗方案治疗晚期胰腺癌的疗效]
Ai Zheng. 2007 Aug;26(8):890-4.
4
Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials.吉西他滨联合治疗与单纯吉西他滨治疗晚期胰腺癌的比较：九项随机对照试验的荟萃分析
Hepatobiliary Pancreat Dis Int. 2017 Jun;16(3):236-244. doi: 10.1016/s1499-3872(17)60022-5.
5
The efficacy and safety of gemcitabine-based combination therapy gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis.吉西他滨联合治疗与单纯吉西他滨治疗晚期胰腺癌的疗效和安全性：一项系统评价和荟萃分析。
J Gastrointest Oncol. 2022 Aug;13(4):1967-1980. doi: 10.21037/jgo-22-624.
6
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study.序贯吉西他滨与铂类药物对比吉西他滨与铂类药物一线联合用于晚期胰腺癌治疗的回顾性研究
Int J Clin Oncol. 2014 Aug;19(4):634-42. doi: 10.1007/s10147-013-0622-x.
7
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.吉西他滨对比吉西他滨联合舒尼替尼治疗晚期胰腺癌的前瞻性随机 II 期试验：CESAR（中欧癌症药物研究学会-欧洲肿瘤内科学会）研究。
Eur J Cancer. 2015 Jan;51(1):27-36. doi: 10.1016/j.ejca.2014.10.010. Epub 2014 Nov 5.
8
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.吉西他滨联合奥沙利铂与单用吉西他滨治疗局部晚期或转移性胰腺癌的比较：GERCOR和GISCAD III期试验结果
J Clin Oncol. 2005 May 20;23(15):3509-16. doi: 10.1200/JCO.2005.06.023.
9
Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer.吉西他滨联合卡培他滨与吉西他滨联合或不联合厄洛替尼作为晚期胰腺癌患者一线化疗的比较
Cancer Res Treat. 2015 Apr;47(2):266-73. doi: 10.4143/crt.2013.158. Epub 2014 Aug 29.
10
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.吉西他滨联合纳米白蛋白结合型紫杉醇，随后单药吉西他滨维持治疗作为老年局部晚期或转移性胰腺癌患者的一线治疗方案。
J Geriatr Oncol. 2020 May;11(4):647-651. doi: 10.1016/j.jgo.2019.08.008. Epub 2019 Aug 27.
本文引用的文献
1
The efficacy and safety of gemcitabine-based combination therapy gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis.吉西他滨联合治疗与单纯吉西他滨治疗晚期胰腺癌的疗效和安全性：一项系统评价和荟萃分析。
J Gastrointest Oncol. 2022 Aug;13(4):1967-1980. doi: 10.21037/jgo-22-624.
2
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma.辅助吉西他滨联合卡培他滨与吉西他滨单药治疗胰腺导管腺癌的真实世界证据。
Int J Cancer. 2022 May 15;150(10):1654-1663. doi: 10.1002/ijc.33916. Epub 2021 Dec 31.
3
Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测晚期胃癌患者的化疗反应及预后。
BMC Cancer. 2019 Jul 8;19(1):672. doi: 10.1186/s12885-019-5903-y.
4
Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.吉西他滨联合 S-1 方案对比吉西他滨治疗不可切除胰腺癌的随机对照研究。
Cancer Chemother Pharmacol. 2014 Feb;73(2):389-96. doi: 10.1007/s00280-013-2368-6. Epub 2013 Dec 10.
5
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.可切除胰腺癌新辅助化疗的随机2期试验：单纯吉西他滨与吉西他滨联合顺铂对比
Ann Surg Oncol. 2007 Jul;14(7):2088-96. doi: 10.1245/s10434-007-9384-x. Epub 2007 Apr 24.
6
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.吉西他滨单药或联合顺铂治疗局部晚期和/或转移性胰腺癌患者：意大利南部肿瘤学组的一项前瞻性、随机III期研究
Cancer. 2002 Feb 15;94(4):902-10.
Zotero 插件